KUNMI O MAJEKODUNMI

Allopathic & Osteopathic Physicians|Internal Medicine GLEN BURNIE, MD NPI 1497791917

General Payments — all program years on this page

$2,735.09

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 129
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $466.68 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $326.7013
Education $139.982

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Astellas Pharma US Inc $139.982
ABBVIE INC. $92.612
Novo Nordisk AS $79.904
DEXCOM, INC. $44.011
Sumitomo Pharma America, Inc. $38.692
Ardelyx, Inc. $29.512
ATRICURE, INC. $26.141
GlaxoSmithKline, LLC. $15.841

By program year

Program yearAmountRecords
2018 $184.1916
2019 $386.8319
2020 $154.424
2021 $730.1927
2022 $323.7521
2023 $489.0327
2024 $466.6815

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096595540 Novo Nordisk Inc $16.80 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096602727 Novo Nordisk Inc $20.70 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096612626 Novo Nordisk Inc $18.29 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097766143 Novo Nordisk Inc $24.11 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104933958 ABBVIE INC. $73.16 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104933963 ABBVIE INC. $19.45 05/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116421855 GlaxoSmithKline, LLC. $15.84 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132879391 ATRICURE, INC. $26.14 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139345102 Astellas Pharma US Inc $64.99 03/06/2024 Education Undisputed 01/23/2026 View at CMS
1139408671 Astellas Pharma US Inc $74.99 09/30/2024 Education Undisputed 01/23/2026 View at CMS
1146693580 Ardelyx, Inc. $13.77 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146693582 Ardelyx, Inc. $15.74 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148885170 Sumitomo Pharma America, Inc. $25.44 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148885172 Sumitomo Pharma America, Inc. $13.25 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153315108 Dexcom, Inc. $44.01 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.